Painless thyroiditis occurring during long-term treatment with interferon alfa in a patient with chronic active hepatitis C

Southern Medical Journal

Volumn 89, Issue 1, 1996, Pages 81-84

  Uchida, Kenzo ^a   Matsui, Akira ^b   Nakano, Shigeru ^b   Kigoshi, Toshikazu ^b   Morimoto, Shinpei ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

AGED; ARTICLE; AUTOIMMUNITY; CASE REPORT; CHRONIC ACTIVE HEPATITIS; HEPATITIS C; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOTHERAPY; MALE; THYROIDITIS;

EID: 0030066503     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199601000-00015     Document Type: Article

References (15)

1. Hoofnagle JH, Peters M, Mullen KD, et al: Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95:1318-1325
2. Biscegic AMD, Martin P, Kassianides C, et al: Recombinant interferon alpha therapy for chronic hepatitis C, a randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321:1506-1510
3. Ronnblom LE, Alm GV, Oberg KE: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 115:178-183
4. McLaughlin P, Talpaz M, Quesada JR, et al: Immune thrombocytopenia following α-interferon therapy in patients with cancer. JAMA 1985; 254:1353-1354
5. Baudin E, Marcellin P, Pouteau M, et al: Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol 1993; 39:657-661
6. Chung Y-H, Shong YK: Development of thyroid autoimmunity after administration of recombinant human interferon-α2b for chronic viral hepatitis. Am J Gastroenterol 1993; 88:244-247
7. Gisslinger H, Gilly B, Woloszczuk W, et al: Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol 1992; 90:363-367
8. Fentiman LS, Balkwill FR, Thomas BS, et al: An autoimmune etiology for hypothyroidism following interferon therapy for breast cancer. Eur J Cancer Clin Oncol 1988; 24:1299-1303
9. Beever K, Bradbury J, Phillips D, et al: Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem 1989; 35:1949-1954
10. Schultz M, Muller R, Von Zur Muhlen A, et al: Induction of hyperthyroidism by interferon-α-2b. Lancet 1989; 1:1452
11. Papo T, Oksenhendler E, Izembart M, et al: Antithyroid hormone antibodies induced by interferon-α. J Clin Endocrinol Metab 1992; 75:1484-1486
12. Taniguchi Y, Murakami T, Nakanishi K, et al: Two cases of hypothyroidism associated with alpha-interferon therapy. Intern Med 1992; 31:373-376
13. Davies T, Piccinini F: Intrathyroidal MHC class II antigen expression and thyroid autoimmunity. Endocrinol Metab Clin North Am 1987; 16:77-79
14. Fentiman IS, Thomas BS, Balkwill FR, et al: Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1985; 1:116
15. Buller R, Holmes K, Hugin A, et al: Induction of cytotoxic T cell responses in vivo in the absence of CD4 helper cells. Nature 1987; 328:77-79